Myosin 9 (MYH9) (Middle Region) Peptide
MYH9
适用: 人
宿主: 合成
BP, WB
Quick Overview for Myosin 9 (MYH9) (Middle Region) Peptide (ABIN980436)
抗原
Myosin 9 (MYH9)
宿主
人
资源
合成
应用范围
Blocking Peptide (BP), Western Blotting (WB)
-
-
蛋白结构域
- Middle Region
-
产品特性
- This is a synthetic peptide designed for use in combination with anti-MYH9 antibody (Catalog #: ARP48072_P050). It may block above mentioned antibody from binding to its target protein in western blot and/or immunohistochecmistry under proper experimental settings. There is no guarantee for its use in other applications.
-
纯化方法
- Purified
-
-
-
-
应用备注
- Each Investigator should determine their own optimal working dilution for specific applications.
-
限制
- 仅限研究用
-
-
-
状态
- Lyophilized
-
溶解方式
- Add 100 μL of sterile PBS. Final peptide concentration is 1 mg/mL in PBS.
-
浓度
- 1 mg/mL
-
缓冲液
- Final peptide concentration is 1 mg/mL in PBS.
-
注意事项
- Avoid repeated freeze-thaw cycles.
-
储存条件
- -20 °C
-
储存方法
- For longer periods of storage, store at -20°C. Avoid repeat freeze-thaw cycles.
-
-
- Myosin 9 (MYH9)
-
背景
-
MYH9 is a myosin IIA heavy chain that contains an IQ domain and a myosin head-like domain. The protein is involved in several important functions, including cytokinesis, cell motility and maintenance of cell shape. Defects in MYH9 are the cause of non-syndromic sensorineural deafness autosomal dominant type 17, Epstein syndrome, Alport syndrome with macrothrombocytopenia, Sebastian syndrome, Fechtner syndrome and macrothrombocytopenia with progressive sensorineural deafness.
Alias Symbols: DFNA17, EPSTS, FTNS, MGC104539, MHA, NMHC-II-A, NMMHCA, BDPLT6, NMMHC-IIA
Protein Interaction Partner: ASCC2,CD163,CXCR4,GRIN1,MEN1,MYBPC3,MYH10,MYL9,MYOM1,MYOM2,OVGP1,PTPN6,S100A4,TTN,TUFM,ASCC2,EPB41,MARK4,MYL9,PRKCE,USP1,USP45
Protein Size: 1960 -
分子量
- 226 kDa
-
基因ID
- 4627
-
NCBI登录号
- NM_002473, NP_002464
-
UniProt
- P35579
抗原
-
You are here:
